Skip to content

Bayer & Co: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Bayer & Co

BE 0474.687.712
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€203
2024 · -€490+€287
Equity
-€19,097
2024 · -€18,895-€203
Cash
€9
2024 · €78-€69
Balance sheet total
€13,051
2024 · €12,137+€914

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€984

    up €984 (+8.2%), from €12,058 to €13,042

Equity and liabilities
  • Other debts +€1,786

    up €1,786 (+7.1%), from €25,301 to €27,088

  • Trade debts -€670

    down €670 (-91.7%), from €730 to €61

  • Profit (loss) carried forward -€203

    down €203 (-0.4%), from -€50,040 to -€50,243

Income statement
  • Financial income +€308

    up €308 (+84.8%), from €363 to €672

  • Gross operating margin -€25

    down €25 (-3.4%), from -€730 to -€755

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€490
Gross operating margin -€25
Financial income +€308
Financial charges +€4
Result 2025 -€203

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€69
Investment €0
Financing €0
Cash 2024 €78
Net result for the year -€203
Receivables within one year -€984
Trade debts -€670
Other debts +€1,786
Cash 2025 €9
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €12,137 €13,051 +€914 +7.5%
Current assets 29/58 €12,137 €13,051 +€914 +7.5%
Amounts receivable within one year 40/41 €12,058 €13,042 +€984 +8.2%
Other amounts receivable 41 €12,058 €13,042 +€984 +8.2%
Cash at bank and in hand 54/58 €78 €9 -€69 -88.8%
Total equity and liabilities 10/49 €12,137 €13,051 +€914 +7.5%
Equity 10/15 -€18,895 -€19,097 -€203 -1.1%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €24,945 €24,945 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Tax-exempt reserves 132 €23,085 €23,085 = 0.0%
Profit (loss) carried forward 14 -€50,040 -€50,243 -€203 -0.4%
Provisions and deferred taxes 16 €5,000 €5,000 = 0.0%
Provisions for liabilities and charges 160/5 €5,000 €5,000 = 0.0%
Taxes 161 €5,000 €5,000 = 0.0%
Amounts payable 17/49 €26,031 €27,148 +€1,117 +4.3%
Amounts payable within one year 42/48 €26,031 €27,148 +€1,117 +4.3%
Trade debts 44 €730 €61 -€670 -91.7%
Suppliers 440/4 €730 €61 -€670 -91.7%
Other amounts payable 47/48 €25,301 €27,088 +€1,786 +7.1%
Gross operating margin 9900 -€730 -€755 -€25 -3.4%
Operating profit (loss) 9901 -€730 -€755 -€25 -3.4%
Financial income 75/76B €363 €672 +€308 +84.8%
Recurring financial income 75 €363 €672 +€308 +84.8%
Financial charges 65/66B €123 €119 -€4 -2.8%
Recurring financial charges 65 €123 €119 -€4 -2.8%
Profit (loss) for the period before taxes 9903 -€490 -€203 +€287 +58.6%
Profit (loss) for the period 9904 -€490 -€203 +€287 +58.6%
Profit (loss) for the period to be appropriated 9905 -€490 -€203 +€287 +58.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.